Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

AIDS oncology.

P G O'Connor¹, D T Scadden

¹AIDS Research Center and MGH Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Infectious Disease Clinics of North America

|January 6, 2001

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Microbiome depletion rejuvenates the aging brain.

bioRxiv : the preprint server for biology·2026

Same author

Hematopoietic Stem Cell and Its Bone Marrow Niche.

Current topics in developmental biology·2016

Same author

A novel role for CCL3 (MIP-1α) in myeloma-induced bone disease via osteocalcin downregulation and inhibition of osteoblast function.

Leukemia·2011

Same author

A niche opportunity for stem cell therapeutics.

Gene therapy·2007

Same author

Regulation of hematopoietic stem cell growth.

Leukemia·2004

Same author

Osteoblastic cells regulate the haematopoietic stem cell niche.

Nature·2003

Same journal

Prevention and Control of Clostridioides difficile Infection for the Infectious Diseases Clinician.

Infectious disease clinics of North America·2026

Same journal

Infection Control Strategies to Prevent Emergence and Transmission of Resistant Gram-Negative Bacteria.

Infectious disease clinics of North America·2026

Same journal

Preventing the Spread of Tuberculosis in Health Care Settings.

Infectious disease clinics of North America·2026

Same journal

Threats to Success: Principles of Infection Prevention and Control in Health Care Settings, Part 2: Device and Pathogen Management.

Infectious disease clinics of North America·2026

Same journal

Ventilator-Associated Events: Surveillance and Prevention.

Infectious disease clinics of North America·2026

Same journal

Nosocomial Fungal Infections: Epidemiology, Control Strategies, and Prevention of Candida and Other Yeasts.

Infectious disease clinics of North America·2026

See all related articles

The outlook for HIV malignancies like Kaposi's sarcoma has improved with highly active antiretroviral therapy (HAART) and chemotherapy. Novel biologic therapies are under investigation for better treatment outcomes.

Area of Science:

Oncology
Infectious Diseases
Immunology

Background:

Patients with Human Immunodeficiency Virus (HIV) exhibit increased incidence of certain malignancies, including Kaposi's sarcoma, non-Hodgkin's lymphoma, Hodgkin's disease, and squamous cell carcinoma.
These HIV-associated cancers pose significant clinical challenges.

Purpose of the Study:

To review current knowledge on HIV malignancies.
To cover epidemiology, pathogenesis, clinical manifestations, and treatment strategies for these cancers.

Main Methods:

Literature review of HIV malignancies.
Synthesis of information on epidemiology, pathogenesis, clinical presentation, and therapeutic approaches.

Main Results:

Related Experiment Videos

Highly active antiretroviral therapy (HAART) and aggressive cytotoxic therapies have improved patient outcomes.

Novel biologic therapies with improved side effect profiles are emerging.

Conclusions:

Significant advancements in managing HIV malignancies have been achieved through combined antiretroviral and cytotoxic treatments.
Ongoing research into biologic therapies promises further improvements in patient care and prognosis for HIV-associated cancers.